Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Best Practice & Research. Clinical Endocrinology & Metabolism|March 15, 2016
Management of follow-up of neuroendocrine neoplasiasUlrich-Frank Pape, Sebastian Maasberg, Henning Jann, et al.
Cancer Letters|May 7, 2016
Tissue-infiltrating plasma cells are an important source of carboxylesterase 2 contributing to the therapeutic efficacy of prodrugsAnja A Kühl, Ulrike Erben, Constanze Cieluch, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|December 24, 2004
Percutaneous peripheral atherectomy of femoropopliteal stenoses using a new-generation device: six-month results from a single-center experienceThomas Zeller, Aljoscha Rastan, Uwe Schwarzwälder, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 14, 2013
Outcome and toxicity of salvage therapy with 177Lu-octreotate in patients with metastatic gastroenteropancreatic neuroendocrine tumoursAmir Sabet, Torjan Haslerud, Ulrich-Frank Pape, et al.
Neuroendocrinology|September 5, 2019
Peritoneal Carcinomatosis in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: Clinical Impact and Effectiveness of the Available Therapeutic OptionsElettra Merola, Vikas Prasad, Andreas Pascher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2013
Long-term hematotoxicity after peptide receptor radionuclide therapy with 177Lu-octreotateAmir Sabet, Khaled Ezziddin, Ulrich-Frank Pape, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 2, 2024
Lymph node metastases are more frequent in paediatric appendiceal NET ≥1.5 cm but without impact on outcome - Data from the German MET studiesMichaela Kuhlen, Marina Kunstreich, Ulrich-Frank Pape, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2013
Accurate assessment of long-term nephrotoxicity after peptide receptor radionuclide therapy with (177)Lu-octreotateAmir Sabet, Khaled Ezziddin, Ulrich-Frank Pape, et al.
Nutrients|October 14, 2023
Predictive Potential of Biomarkers of Intestinal Barrier Function for Therapeutic Management with Teduglutide in Patients with Short Bowel SyndromeJanine Büttner, Elisabeth Blüthner, Sophie Greif, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 20, 2011
Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumoursNils F Schreiter, Winfried Brenner, Munenobu Nogami, et al.
Pageof 12